Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
BACKGROUND: Genome-wide association studies have identified several common genetic variants associated with breast cancer risk. It is likely, however, that a substantial proportion of such loci have not yet been discovered. METHODS: We compared 296,114 tagging single-nucleotide polymorphisms in 169...
| প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| বিন্যাস: | Journal article |
| ভাষা: | English |
| প্রকাশিত: |
2011
|
| _version_ | 1826295330941960192 |
|---|---|
| author | Fletcher, O Johnson, N Orr, N Hosking, F Gibson, L Walker, K Zelenika, D Gut, I Heath, S Palles, C Coupland, B Broderick, P Schoemaker, M Jones, M Williamson, J Chilcott-Burns, S Tomczyk, K Simpson, G Jacobs, K Chanock, S Hunter, D Tomlinson, I Swerdlow, A Ashworth, A Ross, G |
| author_facet | Fletcher, O Johnson, N Orr, N Hosking, F Gibson, L Walker, K Zelenika, D Gut, I Heath, S Palles, C Coupland, B Broderick, P Schoemaker, M Jones, M Williamson, J Chilcott-Burns, S Tomczyk, K Simpson, G Jacobs, K Chanock, S Hunter, D Tomlinson, I Swerdlow, A Ashworth, A Ross, G |
| author_sort | Fletcher, O |
| collection | OXFORD |
| description | BACKGROUND: Genome-wide association studies have identified several common genetic variants associated with breast cancer risk. It is likely, however, that a substantial proportion of such loci have not yet been discovered. METHODS: We compared 296,114 tagging single-nucleotide polymorphisms in 1694 breast cancer case subjects (92% with two primary cancers or at least two affected first-degree relatives) and 2365 control subjects, with validation in three independent series totaling 11,880 case subjects and 12,487 control subjects. Odds ratios (ORs) and associated 95% confidence intervals (CIs) in each stage and all stages combined were calculated using unconditional logistic regression. Heterogeneity was evaluated with Cochran Q and I(2) statistics. All statistical tests were two-sided. RESULTS: We identified a novel risk locus for breast cancer at 9q31.2 (rs865686: OR = 0.89, 95% CI = 0.85 to 0.92, P = 1.75 × 10(-10)). This single-nucleotide polymorphism maps to a gene desert, the nearest genes being Kruppel-like factor 4 (KLF4, 636 kb centromeric), RAD23 homolog B (RAD23B, 794 kb centromeric), and actin-like 7A (ACTL7A, 736 kb telomeric). We also identified two variants (rs3734805 and rs9383938) mapping to 6q25.1 estrogen receptor 1 (ESR1), which were associated with breast cancer in subjects of northern European ancestry (rs3734805: OR = 1.19, 95% CI = 1.11 to 1.27, P = 1.35 × 10(-7); rs9383938: OR = 1.18, 95% CI = 1.11 to 1.26, P = 1.41 × 10(-7)). A variant mapping to 10q26.13, approximately 300 kb telomeric to the established risk locus within the second intron of FGFR2, was also associated with breast cancer risk, although not at genome-wide statistical significance (rs10510102: OR = 1.12, 95% CI = 1.07 to 1.17, P = 1.58 × 10(-6)). CONCLUSIONS: These findings provide further evidence on the role of genetic variation in the etiology of breast cancer. Fine mapping will be needed to identify causal variants and to determine their functional effects. |
| first_indexed | 2024-03-07T03:59:22Z |
| format | Journal article |
| id | oxford-uuid:c400deda-436f-4ff7-b84c-26e49225be7f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:59:22Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:c400deda-436f-4ff7-b84c-26e49225be7f2022-03-27T06:20:32ZNovel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c400deda-436f-4ff7-b84c-26e49225be7fEnglishSymplectic Elements at Oxford2011Fletcher, OJohnson, NOrr, NHosking, FGibson, LWalker, KZelenika, DGut, IHeath, SPalles, CCoupland, BBroderick, PSchoemaker, MJones, MWilliamson, JChilcott-Burns, STomczyk, KSimpson, GJacobs, KChanock, SHunter, DTomlinson, ISwerdlow, AAshworth, ARoss, G BACKGROUND: Genome-wide association studies have identified several common genetic variants associated with breast cancer risk. It is likely, however, that a substantial proportion of such loci have not yet been discovered. METHODS: We compared 296,114 tagging single-nucleotide polymorphisms in 1694 breast cancer case subjects (92% with two primary cancers or at least two affected first-degree relatives) and 2365 control subjects, with validation in three independent series totaling 11,880 case subjects and 12,487 control subjects. Odds ratios (ORs) and associated 95% confidence intervals (CIs) in each stage and all stages combined were calculated using unconditional logistic regression. Heterogeneity was evaluated with Cochran Q and I(2) statistics. All statistical tests were two-sided. RESULTS: We identified a novel risk locus for breast cancer at 9q31.2 (rs865686: OR = 0.89, 95% CI = 0.85 to 0.92, P = 1.75 × 10(-10)). This single-nucleotide polymorphism maps to a gene desert, the nearest genes being Kruppel-like factor 4 (KLF4, 636 kb centromeric), RAD23 homolog B (RAD23B, 794 kb centromeric), and actin-like 7A (ACTL7A, 736 kb telomeric). We also identified two variants (rs3734805 and rs9383938) mapping to 6q25.1 estrogen receptor 1 (ESR1), which were associated with breast cancer in subjects of northern European ancestry (rs3734805: OR = 1.19, 95% CI = 1.11 to 1.27, P = 1.35 × 10(-7); rs9383938: OR = 1.18, 95% CI = 1.11 to 1.26, P = 1.41 × 10(-7)). A variant mapping to 10q26.13, approximately 300 kb telomeric to the established risk locus within the second intron of FGFR2, was also associated with breast cancer risk, although not at genome-wide statistical significance (rs10510102: OR = 1.12, 95% CI = 1.07 to 1.17, P = 1.58 × 10(-6)). CONCLUSIONS: These findings provide further evidence on the role of genetic variation in the etiology of breast cancer. Fine mapping will be needed to identify causal variants and to determine their functional effects. |
| spellingShingle | Fletcher, O Johnson, N Orr, N Hosking, F Gibson, L Walker, K Zelenika, D Gut, I Heath, S Palles, C Coupland, B Broderick, P Schoemaker, M Jones, M Williamson, J Chilcott-Burns, S Tomczyk, K Simpson, G Jacobs, K Chanock, S Hunter, D Tomlinson, I Swerdlow, A Ashworth, A Ross, G Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. |
| title | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. |
| title_full | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. |
| title_fullStr | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. |
| title_full_unstemmed | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. |
| title_short | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. |
| title_sort | novel breast cancer susceptibility locus at 9q31 2 results of a genome wide association study |
| work_keys_str_mv | AT fletchero novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT johnsonn novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT orrn novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT hoskingf novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT gibsonl novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT walkerk novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT zelenikad novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT guti novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT heaths novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT pallesc novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT couplandb novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT broderickp novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT schoemakerm novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT jonesm novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT williamsonj novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT chilcottburnss novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT tomczykk novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT simpsong novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT jacobsk novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT chanocks novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT hunterd novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT tomlinsoni novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT swerdlowa novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT ashwortha novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy AT rossg novelbreastcancersusceptibilitylocusat9q312resultsofagenomewideassociationstudy |